BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 17901245)

  • 1. Inhibition of tissue factor signaling suppresses tumor growth.
    Versteeg HH; Schaffner F; Kerver M; Petersen HH; Ahamed J; Felding-Habermann B; Takada Y; Mueller BM; Ruf W
    Blood; 2008 Jan; 111(1):190-9. PubMed ID: 17901245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor VIIa-induced interaction with integrin controls the release of tissue factor on extracellular vesicles from endothelial cells.
    Rothmeier AS; Versteeg HH; Ruf W
    J Thromb Haemost; 2019 Apr; 17(4):627-634. PubMed ID: 30740873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the integrin-binding site on coagulation factor VIIa required for proangiogenic PAR2 signaling.
    Rothmeier AS; Liu E; Chakrabarty S; Disse J; Mueller BM; Østergaard H; Ruf W
    Blood; 2018 Feb; 131(6):674-685. PubMed ID: 29246902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue factor in cancer progression and angiogenesis.
    Ruf W; Yokota N; Schaffner F
    Thromb Res; 2010 Apr; 125 Suppl 2(0 2):S36-8. PubMed ID: 20434002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tick-derived inhibitor Ixolaris prevents tissue factor signaling on tumor cells.
    Carneiro-Lobo TC; Schaffner F; Disse J; Ostergaard H; Francischetti IM; Monteiro RQ; Ruf W
    J Thromb Haemost; 2012 Sep; 10(9):1849-58. PubMed ID: 22823596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of protease activated receptor 1 and 2 signaling in hypoxia-induced angiogenesis.
    Uusitalo-Jarvinen H; Kurokawa T; Mueller BM; Andrade-Gordon P; Friedlander M; Ruf W
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1456-62. PubMed ID: 17363687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome.
    Redecha P; Franzke CW; Ruf W; Mackman N; Girardi G
    J Clin Invest; 2008 Oct; 118(10):3453-61. PubMed ID: 18802482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of β1 integrins and caveolin-1 by TF/FVIIa promotes IGF-1R signaling and cell survival.
    Åberg M; Edén D; Siegbahn A
    Apoptosis; 2020 Aug; 25(7-8):519-534. PubMed ID: 32458278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.
    Camerer E; Huang W; Coughlin SR
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5255-60. PubMed ID: 10805786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional program induced by factor VIIa-tissue factor, PAR1 and PAR2 in MDA-MB-231 cells.
    Albrektsen T; Sørensen BB; Hjortø GM; Fleckner J; Rao LV; Petersen LC
    J Thromb Haemost; 2007 Aug; 5(8):1588-97. PubMed ID: 17470200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-talk of integrin alpha3beta1 and tissue factor in cell migration.
    Dorfleutner A; Hintermann E; Tarui T; Takada Y; Ruf W
    Mol Biol Cell; 2004 Oct; 15(10):4416-25. PubMed ID: 15254262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue factor as a novel target for treatment of breast cancer.
    Cole M; Bromberg M
    Oncologist; 2013; 18(1):14-8. PubMed ID: 23287882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of tissue factor-induced signaling by endogenous and recombinant tissue factor pathway inhibitor 1.
    Ahamed J; Belting M; Ruf W
    Blood; 2005 Mar; 105(6):2384-91. PubMed ID: 15550483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase-2: A key regulator in coagulation proteases mediated human breast cancer progression through autocrine signaling.
    Das K; Prasad R; Ansari SA; Roy A; Mukherjee A; Sen P
    Biomed Pharmacother; 2018 Sep; 105():395-406. PubMed ID: 29870887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of tissue factor-factor VIIa-factor Xa complex induces activation of the mTOR pathway which regulates migration of human breast cancer cells.
    Jiang X; Zhu S; Panetti TS; Bromberg ME
    Thromb Haemost; 2008 Jul; 100(1):127-33. PubMed ID: 18612547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue Factor/ FVIIa prevents the extrinsic pathway of apoptosis by regulation of the tumor suppressor Death-Associated Protein Kinase 1 (DAPK1).
    Aberg M; Johnell M; Wickström M; Siegbahn A
    Thromb Res; 2011 Feb; 127(2):141-8. PubMed ID: 21168190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of tissue factor in complex with antibody 10H10 reveals the signaling epitope.
    Teplyakov A; Obmolova G; Malia TJ; Wu B; Zhao Y; Taudte S; Anderson GM; Gilliland GL
    Cell Signal; 2017 Aug; 36():139-144. PubMed ID: 28483635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disulfide isomerization switches tissue factor from coagulation to cell signaling.
    Ahamed J; Versteeg HH; Kerver M; Chen VM; Mueller BM; Hogg PJ; Ruf W
    Proc Natl Acad Sci U S A; 2006 Sep; 103(38):13932-7. PubMed ID: 16959886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of PKCα activation in TF/VIIa/PAR2-induced proliferation, migration, and survival of colon cancer cell SW620.
    Wu B; Zhou H; Hu L; Mu Y; Wu Y
    Tumour Biol; 2013 Apr; 34(2):837-46. PubMed ID: 23233043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TF:FVIIa-specific activation of CREB upregulates proapoptotic proteins via protease-activated receptor-2.
    Versteeg HH; Borensztajn KS; Kerver ME; Ruf W; Reitsma PH; Spek CA; Peppelenbosch MP
    J Thromb Haemost; 2008 Sep; 6(9):1550-7. PubMed ID: 18647225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.